{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T19:52:03Z","timestamp":1778356323424,"version":"3.51.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1136\/annrheumdis-2016-210311","type":"journal-article","created":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T04:26:06Z","timestamp":1481775966000},"page":"992-997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trials"],"prefix":"10.1016","volume":"76","author":[{"given":"Charles","family":"Peterfy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibeke","family":"Strand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikkel","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"DiCarlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Countryman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2130-1246","authenticated-orcid":false,"given":"Atul","family":"Deodhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Landew\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veena K","family":"Ranganath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orrin","family":"Troum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip G","family":"Conaghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2016-210311_bib1","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/art.30402","article-title":"American College of Rheumatology Clinical Trial Priorities and Design Conference, July 22\u201323, 2010","volume":"63","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-210311_bib2","unstructured":"Guidance for Industry: Rheumatoid Arthritis: Developing Drug Products for Treatment. http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm"},{"key":"10.1136\/annrheumdis-2016-210311_bib3","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/annrheumdis-2012-202696","article-title":"MRI comes of age in RA clinical trials","volume":"72","author":"Peterfy","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210311_bib4","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1002\/art.38083","article-title":"Review: the utility of magnetic resonance imaging for assessing structural damage in randomized controlled trials in rheumatoid arthritis","volume":"65","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-210311_bib5","series-title":"Applied logistic regression","author":"Hosmer","year":"2013"},{"key":"10.1136\/annrheumdis-2016-210311_bib6","first-page":"198","article-title":"The OMERACT filter for outcome measures in rheumatology","volume":"25","author":"Boers","year":"1998","journal-title":"J Rheum"},{"key":"10.1136\/annrheumdis-2016-210311_bib7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jclinepi.2013.11.013","article-title":"Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0","volume":"67","author":"Boers","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"10.1136\/annrheumdis-2016-210311_bib8","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1136\/annrheumdis-2013-203444","article-title":"Early MRI measures independently predict 1-year and 2-year radiographic progression in rheumatoid arthritis: secondary analysis from a large clinical trial","volume":"73","author":"Baker","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210311_bib9","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/annrheumdis-2014-206934","article-title":"Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritis","volume":"75","author":"Baker","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210311_bib10","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","article-title":"Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial","volume":"58","author":"Cohen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-210311_bib11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/art.30114","article-title":"An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents","volume":"63","author":"Genovese","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-210311_bib12","first-page":"455","article-title":"Responses to early rheumatoid arthritis (RA) to treatment with adalimumab plus methotrexate vs. methotrexate alone: magnetic resonance imaging results from OPTIMA","volume":"69","author":"Peterfy","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210311_bib13","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/annrheumdis-2012-201611","article-title":"Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial","volume":"72","author":"Conaghan","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210311_bib14","first-page":"152","article-title":"Rituximab (RTX) plus methotrexate (MTX) prevents bone erosion and joint-space narrowing (JSN) and reduces synovitis, osteitis as shown on MRI: results from a randomized placebo controlled trial in patient (Pts) with rheumatoid arthritis (RA-SCORE)","volume":"70","author":"Peterfy","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210311_bib15","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1002\/art.30592","article-title":"Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: a magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients","volume":"63","author":"\u00d8stergaard","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-210311_bib16","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1136\/ard.2010.146068","article-title":"Assessment by MRI of inflammation and damage in rheumatoid arthritis patients with methotrexate inadequate response receiving golimumab: results of the GO-FORWARD trial","volume":"70","author":"Conaghan","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210311_bib17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/annrheumdis-2013-eular.2216","article-title":"Treatment effects measured by dynamic contrast enhanced MRI and RAMRIS for rheumatoid arthritis","volume":"72","author":"Beals","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1136\/annrheumdis-2016-210311_bib18","first-page":"S1050","article-title":"Magnetic Resonance Imaging Substudy in a Phase 2b Dose-Ranging Study of Baricitinib, an Oral Janus Kinase 1\/Janus Kinase 2 Inhibitor, in Combination with Traditional Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis","volume":"64","author":"Peterfy","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1136\/annrheumdis-2016-210311_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/annrheumdis-2014-eular.1524","article-title":"MRI results from the AVERT study: a randomized, active-controlled trial to evaluate induction of remission and maintenance of drug-free remission using abatacept in combination with methotrexate or as monotherapy in patients with early RA","volume":"73","author":"Peterfy","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210311_bib20","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/annrheumdis-2013-204537","volume":"74","author":"Axelsen","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210311_bib21","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/annrheumdis-2015-208267","volume":"75","author":"Conaghan","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210311_bib22","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/art.39120","article-title":"Apremilast in Patients With Active Rheumatoid Arthritis: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study","volume":"67","author":"Genovese","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/annrheumdis-2016-210311_bib23","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1002\/art.38851","article-title":"Effects of fostamatinib, an oral spleen tyrosine kinase inhibitor, in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study","volume":"66","author":"Weinblatt","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/annrheumdis-2016-210311_bib24","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/annrheumdis-2013-204762","article-title":"The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy","volume":"73","author":"Conaghan","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-210311_bib25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.3899\/jrheum.131087","article-title":"The OMERACT-RAMRIS Rheumatoid Arthritis Magnetic Resonance Imaging Joint Space Narrowing Score: Intrareader and Interreader Reliability and Agreement with Computed Tomography and Conventional Radiography","volume":"41","author":"D\u00f8hn","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2016-210311_bib26","doi-asserted-by":"crossref","first-page":"R44","DOI":"10.1186\/ar4202","article-title":"Monitoring cartilage loss in the hands and wrists in rheumatoid arthritis with magnetic resonance imaging in a multi-center clinical trial: IMPRESS (NCT00425932)","volume":"15","author":"Peterfy","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2016-210311_bib27","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1186\/ar3861","article-title":"Evaluating joint-space narrowing and cartilage loss in rheumatoid arthritis by using MRI","volume":"14","author":"Peterfy","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1136\/annrheumdis-2016-210311_bib28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2214\/ajr.165.2.7618560","article-title":"Quantification of the volume of articular cartilage in the metacarpophalangeal joints of the hand: accuracy and precision of three-dimensional MR imaging","volume":"165","author":"Peterfy","year":"1995","journal-title":"AJR"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724027547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724027547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2016-210311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T23:23:07Z","timestamp":1737242587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724027547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0003496724027547"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2016-210311","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term changes on MRI predict long-term changes on radiography in rheumatoid arthritis: an analysis by an OMERACT Task Force of pooled data from four randomised controlled trials","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2016-210311","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc. For permission to use (where not already granted under a licence) please go to http:\/\/www.bmj.com\/company\/products-services\/rights-and-licensing. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}